News
20m
Investor's Business Daily on MSNBioNTech Surges On Summit's Coattails. But Can They Take On Merck?BioNTech stock rocketed Wednesday after rival Summit Therapeutics unveiled promising results for a novel approach to lung cancer treatment.
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results